Commit To Purchase Navidea Biopharmaceuticals At $1, Earn 15.7% Annualized Using Options
August 28, 2014 at 11:33 AM EDT
Investors considering a purchase of Navidea Biopharmaceuticals, Inc. (NAVB) stock, but tentative about paying the going market price of $1.29/share, might benefit from considering selling puts among the alternative strategies at their disposal..